Cornercap Investment Counsel’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-13,760
| Closed | -$178K | – | 563 |
|
|
2024
Q2 | $178K | Sell |
13,760
-25
| -0.2% | -$324 | 0.03% | 549 |
|
|
2024
Q1 | $241K | Buy |
13,785
+249
| +2% | +$4.35K | 0.04% | 545 |
|
|
2023
Q4 | $127K | Sell |
13,536
-479
| -3% | -$4.51K | 0.02% | 555 |
|
|
2023
Q3 | $157K | Buy |
+14,015
| New | +$157K | 0.03% | 509 |
|
|
2023
Q2 | – | Sell |
-5,742
| Closed | -$232K | – | 600 |
|
|
2023
Q1 | $232K | Hold |
5,742
| – | – | 0.04% | 486 |
|
|
2022
Q4 | $267K | Buy |
+5,742
| New | +$267K | 0.05% | 479 |
|